Crossmark

China’s new policy for healthcare cost-control based on global budget: a survey of 110 clinicians in hospitals

Crossref DOI link: https://doi.org/10.1186/s12913-019-3921-8

Published Online: 2019-02-01

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yan, Jianzhou

Lin, Hui-Heng

Zhao, Dan

Hu, Yuanjia http://orcid.org/0000-0001-5244-8577
Shao, Rong
Funding

Funding for this research was provided by:

National social science foundation of the national planning office for philosophy and social sciences (15ZDB167)

Universidade de Macau (MYRG2015-00172-ICMS-QRCM, MYRG2016-00144-ICMS-QRCM)

Fundo para o Desenvolvimento das Ciências e da Tecnologia (FDCT013/2015/A1)
License Information

Text and Data Mining valid from 2019-02-01
More Information

Article History

Received: 10 January 2018

Accepted: 22 January 2019

First Online: 1 February 2019

Ethics approval and consent to participate

: This study was approved by the ethics committee of the China Pharmaceutical University. The approval number is CPU2016018. The written informed consent was obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.